Mecasermin rinfabate Recruiting Phase 2 Trials for Intraventricular Hemorrhage / Chronic Lung Disease of Prematurity / Retinopathy of Prematurity (ROP) Prevention

IndicationsStatusPurposePhase
RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT03253263A Clinical Efficacy and Safety Study of SHP607 in Preventing Chronic Lung Disease in Extremely Premature Infants